Last reviewed · How we verify
Gastric acid inhibitors
Gastric acid inhibitors is a Small molecule drug developed by Otsuka Pharmaceutical Co., Ltd.. It is currently in Phase 2 development.
At a glance
| Generic name | Gastric acid inhibitors |
|---|---|
| Sponsor | Otsuka Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma (PHASE2)
- A Randomized, Three-Arm Study Comparing Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg for the Healing of LA Grade B or Higher Reflux Esophagitis at 8 Weeks (NA)
- Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection (PHASE2)
- Albumin-bound Paclitaxel-based Second-line Treatment Regimens for Locally Advanced or Metastatic G/GEJ Adenocarcinoma
- QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors (PHASE2)
- Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy (PHASE2)
- Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy (PHASE4)
- Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Gastric acid inhibitors CI brief — competitive landscape report
- Gastric acid inhibitors updates RSS · CI watch RSS
- Otsuka Pharmaceutical Co., Ltd. portfolio CI
Frequently asked questions about Gastric acid inhibitors
What is Gastric acid inhibitors?
Gastric acid inhibitors is a Small molecule drug developed by Otsuka Pharmaceutical Co., Ltd..
Who makes Gastric acid inhibitors?
Gastric acid inhibitors is developed by Otsuka Pharmaceutical Co., Ltd. (see full Otsuka Pharmaceutical Co., Ltd. pipeline at /company/otsuka).
What development phase is Gastric acid inhibitors in?
Gastric acid inhibitors is in Phase 2.
Related
- Manufacturer: Otsuka Pharmaceutical Co., Ltd. — full pipeline
- Compare: Gastric acid inhibitors vs similar drugs
- Pricing: Gastric acid inhibitors cost, discount & access